Published in Gut on September 02, 2015
Ageing Gut Brain Interactions | NCT03593941
Probiotics and Low Protein Diet in Advanced Chronic Kidney Disease (ProLowCKD) | NCT04204005
Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med (2016) 1.08
Bacterial species involved in the conversion of dietary flavonoids in the human gut. Gut Microbes (2016) 0.94
Lactobacillus-Deficient Cervicovaginal Bacterial Communities Are Associated with Increased HIV Acquisition in Young South African Women. Immunity (2017) 0.91
The microbiota and chronic kidney diseases: a double-edged sword. Clin Transl Immunology (2016) 0.86
A high-resolution map of the gut microbiota in Atlantic salmon (Salmo salar): A basis for comparative gut microbial research. Sci Rep (2016) 0.83
The prebiotic concept and human health: a changing landscape with riboflavin as a novel prebiotic candidate? Eur J Clin Nutr (2016) 0.83
Growing up in a Bubble: Using Germ-Free Animals to Assess the Influence of the Gut Microbiota on Brain and Behavior. Int J Neuropsychopharmacol (2016) 0.82
Influence of Phenol-Enriched Olive Oils on Human Intestinal Immune Function. Nutrients (2016) 0.80
Lactobacilli Reduce Helicobacter pylori Attachment to Host Gastric Epithelial Cells by Inhibiting Adhesion Gene Expression. Infect Immun (2016) 0.79
Microbiome therapeutics - Advances and challenges. Adv Drug Deliv Rev (2016) 0.79
Green tea extract provides extensive Nrf2-independent protection against lipid accumulation and NFκB pro- inflammatory responses during nonalcoholic steatohepatitis in mice fed a high-fat diet. Mol Nutr Food Res (2016) 0.79
Gut Microbiota Conversion of Dietary Ellagic Acid into Bioactive Phytoceutical Urolithin A Inhibits Heme Peroxidases. PLoS One (2016) 0.79
Structural basis for nutrient acquisition by dominant members of the human gut microbiota. Nature (2017) 0.79
Potential role of probiotics in the management of gastric ulcer. Exp Ther Med (2016) 0.79
The Effect of Diet and Exercise on Intestinal Integrity and Microbial Diversity in Mice. PLoS One (2016) 0.79
Bone Marrow T Cells and the Integrated Functions of Recirculating and Tissue-Resident Memory T Cells. Front Immunol (2016) 0.78
Taxonomic Assessment of Rumen Microbiota Using Total RNA and Targeted Amplicon Sequencing Approaches. Front Microbiol (2016) 0.78
Gut microbiota and colorectal cancer. Eur J Clin Microbiol Infect Dis (2017) 0.78
The Gut Microbiota and Immune System Relationship in Human Graft-versus-Host Disease. Mediterr J Hematol Infect Dis (2016) 0.78
Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating TLR4 Signaling to NFκB, Upregulating Expression of microRNA-21. Gastroenterology (2016) 0.77
Gut Bacteria Metabolism Impacts Immune Recovery in HIV-infected Individuals. EBioMedicine (2016) 0.77
Transglutaminases in Dysbiosis As Potential Environmental Drivers of Autoimmunity. Front Microbiol (2017) 0.77
Genome Analysis and Characterisation of the Exopolysaccharide Produced by Bifidobacterium longum subsp. longum 35624™. PLoS One (2016) 0.77
Symbiont-induced odorant binding proteins mediate insect host hematopoiesis. Elife (2017) 0.77
The Role of the Microbiome in Gastrointestinal Cancer. Gastroenterol Clin North Am (2016) 0.77
Gut barrier structure, mucosal immunity and intestinal microbiota in the pathogenesis and treatment of HIV infection. AIDS Res Ther (2016) 0.77
Linking Dietary Patterns with Gut Microbial Composition and Function. Gut Microbes (2016) 0.77
Fresh fruit consumption in relation to incident diabetes and diabetic vascular complications: A 7-y prospective study of 0.5 million Chinese adults. PLoS Med (2017) 0.77
Gut Dysbiosis and Adaptive Immune Response in Diet-induced Obesity vs. Systemic Inflammation. Front Microbiol (2017) 0.77
Mucosa-associated microbiota signature in colorectal cancer. Eur J Clin Microbiol Infect Dis (2017) 0.77
The Surface-Associated Exopolysaccharide of Bifidobacterium longum 35624 Plays an Essential Role in Dampening Host Proinflammatory Responses and Repressing Local TH17 Responses. Appl Environ Microbiol (2016) 0.76
The Gastrointestinal Tract as a Key Target Organ for the Health-Promoting Effects of Dietary Proanthocyanidins. Front Nutr (2017) 0.76
A Critical Evaluation of Bifidobacterial Adhesion to the Host Tissue. Front Microbiol (2016) 0.76
Exercise-induced stress behavior, gut-microbiota-brain axis and diet: a systematic review for athletes. J Int Soc Sports Nutr (2016) 0.76
Health and Disease Imprinted in the Time Variability of the Human Microbiome. mSystems (2017) 0.75
Associations between EBV and CMV Seropositivity, Early Exposures, and Gut Microbiota in a Prospective Birth Cohort: A 10-Year Follow-up. Front Pediatr (2016) 0.75
Host-Microbiome Interaction and Cancer: Potential Application in Precision Medicine. Front Physiol (2016) 0.75
Microbial, metabolomic, and immunologic dynamics in a relapsing genetic mouse model of colitis induced by T-synthase deficiency. Gut Microbes (2016) 0.75
Host-Microbiota Interactions Shape Local and Systemic Inflammatory Diseases. J Immunol (2017) 0.75
Differences in gut microbiota profile between women with active lifestyle and sedentary women. PLoS One (2017) 0.75
Extending colonic mucosal microbiome analysis-assessment of colonic lavage as a proxy for endoscopic colonic biopsies. Microbiome (2016) 0.75
Gut microbial diversity analysis using Illumina sequencing for functional dyspepsia with liver depression-spleen deficiency syndrome and the interventional Xiaoyaosan in a rat model. World J Gastroenterol (2017) 0.75
Dysbiosis and compositional alterations with aging in the gut microbiota of patients with heart failure. PLoS One (2017) 0.75
Angiopoietin-like 4 Mediates Colonic Inflammation by Regulating Chemokine Transcript Stability via Tristetraprolin. Sci Rep (2017) 0.75
Gut Microbiota: A Contributing Factor to Obesity. Front Cell Infect Microbiol (2016) 0.75
Gut microbiota: Changes in gut microbes and host metabolism: squaring the circle? Nat Rev Gastroenterol Hepatol (2016) 0.75
Liver - guardian, modifier and target of sepsis. Nat Rev Gastroenterol Hepatol (2016) 0.75
Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth. Aliment Pharmacol Ther (2017) 0.75
Gland New Psychosis: New Onset Adult Psychosis with Suicidal Ideation and Attempt in the Setting of Thyroid Storm. Case Rep Psychiatry (2017) 0.75
Gut microbiota modulation of chemotherapy efficacy and toxicity. Nat Rev Gastroenterol Hepatol (2017) 0.75
Disturbance in the Mucosa-Associated Commensal Bacteria Is Associated with the Exacerbation of Chronic Colitis by Repeated Psychological Stress; Is That the New Target of Probiotics? PLoS One (2016) 0.75
Microbiota-host interplay at the gut epithelial level, health and nutrition. J Anim Sci Biotechnol (2016) 0.75
Experimental support for the effects of a probiotic/digestive enzyme supplement on serum cholesterol concentrations and the intestinal microbiome. J Transl Med (2016) 0.75
Simultaneous purification of DNA and RNA from microbiota in a single colonic mucosal biopsy. BMC Res Notes (2016) 0.75
A Highly Active Endo-Levanase BT1760 of a Dominant Mammalian Gut Commensal Bacteroides thetaiotaomicron Cleaves Not Only Various Bacterial Levans, but Also Levan of Timothy Grass. PLoS One (2017) 0.75
Suppression of colorectal tumorigenesis by recombinant Bacteroides fragilis enterotoxin-2 in vivo. World J Gastroenterol (2017) 0.75
How Useful Are Monogenic Rodent Models for the Study of Human Non-Alcoholic Fatty Liver Disease? Front Endocrinol (Lausanne) (2016) 0.75
Therapeutic Modulation of Gut Microbiota in Functional Bowel Disorders. J Neurogastroenterol Motil (2017) 0.75
The Development of Irritable Bowel Syndrome: A Prospective Community-Based Cohort Study. Am J Gastroenterol (2016) 0.75
Genome Dynamics of Escherichia coli during Antibiotic Treatment: Transfer, Loss, and Persistence of Genetic Elements In situ of the Infant Gut. Front Cell Infect Microbiol (2017) 0.75
Novel Insights into the Pathogenesis of Hirschsprung's-associated Enterocolitis. Chin Med J (Engl) (2016) 0.75
Why Are Omics Technologies Important to Understanding the Role of Nutrition in Inflammatory Bowel Diseases? Int J Mol Sci (2016) 0.75
The mucosal immune system: master regulator of bidirectional gut-brain communications. Nat Rev Gastroenterol Hepatol (2017) 0.75
MicroRNA-155 promotes the pathogenesis of experimental colitis by repressing SHIP-1 expression. World J Gastroenterol (2017) 0.75
Metaproteogenomics Reveals Taxonomic and Functional Changes between Cecal and Fecal Microbiota in Mouse. Front Microbiol (2017) 0.75
Alternative protein sources in the diet modulate microbiota and functionality in the distal intestine of Atlantic salmon (Salmo salar). Appl Environ Microbiol (2016) 0.75
Intestinal Dysbiosis Is Associated with Altered Short-Chain Fatty Acids and Serum-Free Fatty Acids in Systemic Lupus Erythematosus. Front Immunol (2017) 0.75
Current Hypothesis for the Relationship between Dietary Rice Bran Intake, the Intestinal Microbiota and Colorectal Cancer Prevention. Nutrients (2016) 0.75
Indolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the Finnish Diabetes Prevention Study. Sci Rep (2017) 0.75
Fecal Microbiota-based Therapeutics for Recurrent Clostridium difficile Infection, Ulcerative Colitis and Obesity. EBioMedicine (2016) 0.75
Metabolic syndrome is a risk factor for adenoma occurrence at surveillance colonoscopy: A single-center experience in Korea. Medicine (Baltimore) (2016) 0.75
Modulation of the Gut Microbiota by Krill Oil in Mice Fed a High-Sugar High-Fat Diet. Front Microbiol (2017) 0.75
A Perspective on the Application of Pro-/Synbiotics in Clinical Practice. Front Microbiol (2017) 0.75
Short chain fatty acids ameliorate immune-mediated uveitis partially by altering migration of lymphocytes from the intestine. Sci Rep (2017) 0.75
Preparing the Gut with Antibiotics Enhances Gut Microbiota Reprogramming Efficiency by Promoting Xenomicrobiota Colonization. Front Microbiol (2017) 0.75
Secretome of Intestinal Bacilli: A Natural Guard against Pathologies. Front Microbiol (2017) 0.75
Obesity and Asthma: A Missing Link. Int J Mol Sci (2017) 0.75
The Probiotic VSL#3 Modulates Colonic Macrophages, Inflammation, and Microflora in Acute Trinitrobenzene Sulfonic Acid Colitis. J Histochem Cytochem (2017) 0.75
Safety of Novel Microbes for Human Consumption: Practical Examples of Assessment in the European Union. Front Microbiol (2017) 0.75
Stable engraftment of human microbiota into mice with a single oral gavage following antibiotic conditioning. Microbiome (2017) 0.75
New class of precision antimicrobials redefines role of Clostridium difficile S-layer in virulence and viability. Sci Transl Med (2017) 0.75
Novel Concept of a Heart-Gut Axis in the Pathophysiology of Heart Failure. Korean Circ J (2017) 0.75
Recent urbanization in China is correlated with a Westernized microbiome encoding increased virulence and antibiotic resistance genes. Microbiome (2017) 0.75
Decreased Taxon-Specific IgA Response in Relation to the Changes of Gut Microbiota Composition in the Elderly. Front Microbiol (2017) 0.75
The Microbiome in Visceral Medicine: Inflammatory Bowel Disease, Obesity and Beyond. Visc Med (2017) 0.75
Next-Generation Beneficial Microbes: The Case of Akkermansia muciniphila. Front Microbiol (2017) 0.75
Butyric acid - a well-known molecule revisited. Prz Gastroenterol (2017) 0.75
Systematic Review: The Impact of Cancer Treatment on the Gut and Vaginal Microbiome in Women With a Gynecological Malignancy. Int J Gynecol Cancer (2017) 0.75
The Gut Bacterial Community Composition of Wild Cervus albirostris (White-Lipped Deer) Detected by the 16S Ribosomal RNA Gene Sequencing. Curr Microbiol (2017) 0.75
Stool consistency is significantly associated with pain perception. PLoS One (2017) 0.75
Reproducibility of assessing fecal microbiota in chronic constipation. Neurogastroenterol Motil (2017) 0.75
Distribution and phylogenetic analysis of Blastocystis sp. subtypes isolated from IBD patients and healthy individuals in Iran. Eur J Clin Microbiol Infect Dis (2017) 0.75
The cre-inducer doxycycline lowers cytokine and chemokine transcript levels in the gut of mice. J Appl Genet (2017) 0.75
Efficacy and safety of single fecal microbiota transplantation for Japanese patients with mild to moderately active ulcerative colitis. J Gastroenterol (2016) 0.75
Microbial ecology: human gut microbes associated with obesity. Nature (2006) 36.98
Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A (2005) 33.66
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A (2007) 20.60
Linking long-term dietary patterns with gut microbial enterotypes. Science (2011) 17.30
Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr (1995) 13.30
A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature (2012) 11.68
Diet rapidly and reproducibly alters the human gut microbiome. Nature (2013) 11.04
Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut (2005) 10.95
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature (2012) 10.74
Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans. Science (2011) 8.88
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med (2013) 8.21
Intestinal inflammation targets cancer-inducing activity of the microbiota. Science (2012) 7.54
A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med (2009) 7.45
Gut microbiota composition correlates with diet and health in the elderly. Nature (2012) 6.94
Richness of human gut microbiome correlates with metabolic markers. Nature (2013) 6.93
Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature (2013) 6.07
Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology (2012) 6.04
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol (2012) 5.66
Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol (2005) 5.62
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature (2013) 5.47
Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes (Lond) (2008) 5.03
Human colonic microbiota associated with diet, obesity and weight loss. Int J Obes (Lond) (2008) 4.78
Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis (2009) 4.72
Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples. Genome Biol (2012) 4.68
Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology (2003) 4.40
The keystone-pathogen hypothesis. Nat Rev Microbiol (2012) 4.18
Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology (2009) 4.16
Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases. Cell Host Microbe (2008) 4.14
Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial. Gastroenterology (2015) 3.84
Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut (2004) 3.80
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management. J Crohns Colitis (2012) 3.69
Dietary intervention impact on gut microbial gene richness. Nature (2013) 3.56
Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology (2013) 3.50
Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology (1995) 3.44
Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study. Am J Gastroenterol (2010) 3.32
Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe (2007) 3.28
Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol (2014) 3.26
Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell (2015) 3.13
Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis. Gastroenterology (2015) 3.12
High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiol (2011) 3.11
Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease. Gut (2011) 3.11
Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn's disease, and pouchitis: meta-analysis of randomized controlled trials. Inflamm Bowel Dis (2014) 3.04
Interactions between periodontal bacteria and human oral epithelial cells: Fusobacterium nucleatum adheres to and invades epithelial cells. Infect Immun (2000) 2.95
The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Curr Opin Lipidol (2010) 2.90
Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut Microbes (2010) 2.70
The role of the gut microbiota in nutrition and health. Nat Rev Gastroenterol Hepatol (2012) 2.60
Decline in presumptively protective gut bacterial species and metabolites are paradoxically associated with disease improvement in pediatric Crohn's disease during enteral nutrition. Inflamm Bowel Dis (2014) 2.59
A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat Rev Microbiol (2012) 2.56
Liver autoimmunity triggered by microbial activation of natural killer T cells. Cell Host Microbe (2008) 2.30
Towards the human colorectal cancer microbiome. PLoS One (2011) 2.30
Pleiotropic roles of bile acids in metabolism. Cell Metab (2013) 2.25
Enteric dysbiosis associated with a mouse model of alcoholic liver disease. Hepatology (2010) 2.23
Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe (2013) 2.22
Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol (2013) 2.20
Fat, fibre and cancer risk in African Americans and rural Africans. Nat Commun (2015) 2.12
Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis (2014) 1.96
Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-transferase gene. Environ Microbiol (2009) 1.89
Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans. Am J Clin Nutr (2013) 1.87
Integrated metagenomics/metaproteomics reveals human host-microbiota signatures of Crohn's disease. PLoS One (2012) 1.84
The human small intestinal microbiota is driven by rapid uptake and conversion of simple carbohydrates. ISME J (2012) 1.81
Severity of liver injury in experimental alcoholic liver disease. Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4, and thromboxane B2. Am J Pathol (1993) 1.75
Mechanisms of action of probiotics: recent advances. Inflamm Bowel Dis (2009) 1.75
The itinerary of Streptococcus gallolyticus infection in patients with colonic malignant disease. Lancet Infect Dis (2013) 1.72
Minireview: Gut microbiota: the neglected endocrine organ. Mol Endocrinol (2014) 1.71
Genetically dictated change in host mucus carbohydrate landscape exerts a diet-dependent effect on the gut microbiota. Proc Natl Acad Sci U S A (2013) 1.69
Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. Gut (2012) 1.64
Detection of Campylobacter concisus and other Campylobacter species in colonic biopsies from adults with ulcerative colitis. PLoS One (2011) 1.58
Alteration of local microflora and α-defensins hyper-production in colonic adenoma mucosa. J Clin Gastroenterol (2011) 1.57
Analysis of the gut microbiota in the old order Amish and its relation to the metabolic syndrome. PLoS One (2012) 1.56
Fermentation in the human large intestine: its physiologic consequences and the potential contribution of prebiotics. J Clin Gastroenterol (2011) 1.55
Microbiota of de-novo pediatric IBD: increased Faecalibacterium prausnitzii and reduced bacterial diversity in Crohn's but not in ulcerative colitis. Am J Gastroenterol (2012) 1.54
Perspective: alpha-bugs, their microbial partners, and the link to colon cancer. J Infect Dis (2010) 1.53
Influence of red wine polyphenols and ethanol on the gut microbiota ecology and biochemical biomarkers. Am J Clin Nutr (2012) 1.49
A metagenomic insight into our gut's microbiome. Gut (2012) 1.43
Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. Environ Microbiol (2008) 1.42
Dysbiosis signature of fecal microbiota in colorectal cancer patients. Microb Ecol (2013) 1.37
The first 1000 cultured species of the human gastrointestinal microbiota. FEMS Microbiol Rev (2014) 1.34
Co-occurrence of anaerobic bacteria in colorectal carcinomas. Microbiome (2013) 1.28
Microbial pathways in colonic sulfur metabolism and links with health and disease. Front Physiol (2012) 1.26
Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years? World J Gastroenterol (2014) 1.25
Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis. World J Gastroenterol (2013) 1.22
Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: an immunomodulating antibiotic. J Pediatr Gastroenterol Nutr (2008) 1.20
Small-intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease. Aliment Pharmacol Ther (2009) 1.19
Relevance of protein fermentation to gut health. Mol Nutr Food Res (2011) 1.15
Diet-derived phenols in plasma and tissues and their implications for health. Planta Med (2004) 1.14
Colonization of the human gut by E. coli and colorectal cancer risk. Clin Cancer Res (2013) 1.12
Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease. Gut (2005) 1.09
Contribution of gut bacteria to liver pathobiology. Gastroenterol Res Pract (2010) 1.07
Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial. Eur J Clin Nutr (2012) 1.06
Analysis of the intestinal lumen microbiota in an animal model of colorectal cancer. PLoS One (2014) 1.05
Immunology of the gut and liver: a love/hate relationship. Gut (2008) 1.05
Enteric bacterial protein AvrA promotes colonic tumorigenesis and activates colonic beta-catenin signaling pathway. Oncogenesis (2014) 1.01
Hepatic steatosis after intestinal bypass--prevention and reversal by metronidazole, irrespective of protein-calorie malnutrition. Gastroenterology (1982) 0.99
Some are more equal than others: the role of "keystone" species in the degradation of recalcitrant substrates. Gut Microbes (2013) 0.97
Role of the microbiota and antibiotics in primary sclerosing cholangitis. Biomed Res Int (2013) 0.97
Experimental portal fibrosis produced by intraportal injection of killed nonpathogenic Escherichia coli in rabbits. Gastroenterology (1988) 0.97
Bacterial translocation and changes in the intestinal microbiome associated with alcoholic liver disease. World J Hepatol (2012) 0.95
Commensal bacteria drive endogenous transformation and tumour stem cell marker expression through a bystander effect. Gut (2014) 0.94
Dominant fecal microbiota in newly diagnosed untreated inflammatory bowel disease patients. Gastroenterol Res Pract (2013) 0.90
Effects of selective digestive decontamination (SDD) on the gut resistome. J Antimicrob Chemother (2014) 1.59
Early-life environmental variation affects intestinal microbiota and immune development in new-born piglets. PLoS One (2014) 0.91
Early changes in microbial colonization selectively modulate intestinal enzymes, but not inducible heat shock proteins in young adult Swine. PLoS One (2014) 0.87
The colonization dynamics of the gut microbiota in tilapia larvae. PLoS One (2014) 0.84
Effects of pectin supplementation on the fermentation patterns of different structural carbohydrates in rats. Mol Nutr Food Res (2016) 0.81
Cultivation-Based and Molecular Assessment of Bacterial Diversity in the Rhizosheath of Wheat under Different Crop Rotations. PLoS One (2015) 0.78
Microbial Community Response of an Organohalide Respiring Enrichment Culture to Permanganate Oxidation. PLoS One (2015) 0.78
Genomic, proteomic, and biochemical analysis of the organohalide respiratory pathway in Desulfitobacterium dehalogenans. J Bacteriol (2014) 0.78
Pili-like proteins of Akkermansia muciniphila modulate host immune responses and gut barrier function. PLoS One (2017) 0.77
Effects of pectin on fermentation characteristics, carbohydrate utilization, and microbial community composition in the gastrointestinal tract of weaning pigs. Mol Nutr Food Res (2016) 0.77
The cellular lipids of Romboutsia. Biochim Biophys Acta (2016) 0.75
Fungi found in Mediterranean and North Sea sponges: how specific are they? PeerJ (2017) 0.75
Comparative gut microbiota and resistome profiling of intensive care patients receiving selective digestive tract decontamination and healthy subjects. Microbiome (2017) 0.75
Complete Genome Sequence of Eubacterium hallii Strain L2-7. Genome Announc (2017) 0.75